Eli Lilly and Company

Miami University

Robert Brown Peery

Paul Luther Skatrud

Jo Ann Hoskins

Patti J Treadway

Michele Louise Young Bellido

Maarten A De Waard

Alan C Andrade

Q May Wang

Stanley Richard Jaskunas, Jr

Paul R Rosteck, Jr

Genshi Zhao

Chyun-Yeh Earnest Wu

Michele Louise Bellido

Pamela Kay Rockey

Paul Robert Rosteck, Jr

Jnanendra K Bhattacharjee

Stanley Gene Burgett

Matthew Barry Tobin

Susan Jane Thornewell

Richard C Garrad

The invention provides isolated nucleic acid compounds encoding the 454 gene of . Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene HI0454

The invention provides isolated nucleic acid compounds encoding HI1648 of Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene sequence HI1648

The invention provides isolated nucleic acid compounds encoding FtsZ of Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene sequence FtsZ

The invention provides isolated nucleic acid compounds encoding enzyme mraY of,Also provided are vectors and transformed host cells for expressing the encoded enzyme, and a method for identifying compounds that inhibit said enzyme.

Streptococcus pneumoniae gene sequence mraY

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of,Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of,atrD are also provided. The invention further provides assays which utilize these transformed host cells.

Multiple drug resistance gene atrD of Aspergillus nidulans

The invention provides isolated nucleic acid compounds encoding dnaG of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene sequence dnaG

The invention provides isolated nucleic acid compounds encoding a novel MTG of Staphylococcus aureus. Also provided are vectors and transformed heterologous host cells for expressing the MTG and a method for identifying compounds that bind and/or inhibit the enzymatic activity of the MTG.

Monofunctional glycosyltransferase of Staphylococcus aureus

The invention provides isolated nucleic acid compounds encoding FtsH of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Strepococcus pneumoniae gene sequence FtsH

The invention provides isolated nucleic acid compounds encoding HI1146 of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene sequence HI1146

The invention provides isolated nucleic acid compounds encoding Era of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniaegene sequence era

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus nidulans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus nidulans atrC are also provided. The invention further provides assays which utilize these transformed host cells.

Multiple drug resistance gene atrc of Aspergillus nidulans

The invention provides isolated nucleic acid compounds encoding FtsY of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus pneumoniae gene sequence FtsY

Multiple drug resistance gene ATRC of aspergillus nidulans

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus nidulans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus nidulans atrD are also provided. The invention further provides assays which utilize these transformed host cells.

Growing community of inventors

Brownsburg, IN, United States of America

Robert Brown Peery